Results from a Phase IIA Parallel Group Study of JNJ-40346527, an Oral CSF-1R Inhibitor, in Patients with Active Rheumatoid Arthritis despite Disease-modifying Antirheumatic Drug Therapy (Q38406862)
Jump to navigation
Jump to search
scientific article published on August 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Results from a Phase IIA Parallel Group Study of JNJ-40346527, an Oral CSF-1R Inhibitor, in Patients with Active Rheumatoid Arthritis despite Disease-modifying Antirheumatic Drug Therapy |
scientific article published on August 2015 |
Statements
1 reference
Results from a Phase IIA Parallel Group Study of JNJ-40346527, an Oral CSF-1R Inhibitor, in Patients with Active Rheumatoid Arthritis despite Disease-modifying Antirheumatic Drug Therapy (English)
1 reference
Robin L Thurmond
1 reference
Mark C Genovese
1 reference
Elizabeth Hsia
1 reference
Stanley M Belkowski
1 reference
Caly Chien
1 reference
Tara Masterson
1 reference
Carl L Manthey
1 reference
Xiaoyu David Yan
1 reference
Tingting Ge
1 reference
Carol Franks
1 reference
Andrew Greenspan
1 reference
1 August 2015
1 reference
1 reference
42
1 reference
10
1 reference
1752-1760
1 reference
Identifiers
1 reference
1 reference